Brigitte Royer‐Pokora

9.1k total citations · 2 hit papers
118 papers, 5.5k citations indexed

About

Brigitte Royer‐Pokora is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brigitte Royer‐Pokora has authored 118 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 23 papers in Genetics and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brigitte Royer‐Pokora's work include Renal and related cancers (44 papers), Renal cell carcinoma treatment (14 papers) and Acute Myeloid Leukemia Research (12 papers). Brigitte Royer‐Pokora is often cited by papers focused on Renal and related cancers (44 papers), Renal cell carcinoma treatment (14 papers) and Acute Myeloid Leukemia Research (12 papers). Brigitte Royer‐Pokora collaborates with scholars based in Germany, United States and United Kingdom. Brigitte Royer‐Pokora's co-authors include Thomas Graf, Matthias Drechsler, Valerié Schumacher, Anthony P. Monaco, Sabra C. Goff, Louis M. Kunkel, Robert L. Baehner, Peter E. Newburger, William A. Haseltine and Stuart H. Orkin and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Brigitte Royer‐Pokora

114 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region

1991 699 citations Matthias Drechsler, Brigitte Royer‐Pokora et al. profile →
Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location

1986 665 citations Brigitte Royer‐Pokora et al. profile →

Peers

Countries citing papers authored by Brigitte Royer‐Pokora

Since Specialization

Citations

This map shows the geographic impact of Brigitte Royer‐Pokora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Royer‐Pokora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Royer‐Pokora more than expected).

Fields of papers citing papers by Brigitte Royer‐Pokora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Royer‐Pokora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Royer‐Pokora. The network helps show where Brigitte Royer‐Pokora may publish in the future.

Co-authorship network of co-authors of Brigitte Royer‐Pokora

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Royer‐Pokora. A scholar is included among the top collaborators of Brigitte Royer‐Pokora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Royer‐Pokora. Brigitte Royer‐Pokora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor 2021 ·Pediatric Blood & Cancer ·(unknown), Noah Berlow, Michael V. Ortiz, Filemon S. Dela Cruz, (unknown), (unknown), (unknown), (unknown), Joel Michalek, (unknown), (unknown), (unknown), Brigitte Royer‐Pokora, Renata Veselská, Andrew L. Kung, Charles Keller	8
2	Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations 2020 ·Cancers ·Brigitte Royer‐Pokora, Maike Busch, (unknown), Mathias Schmidt, Manfred Beier, (unknown), Hölger Thiele, Jaume Mora	7
3	Reduction of the tumorigenic potential of human retinoblastoma cell lines byTFF1overexpression involves p53/caspase signaling and miR-18a regulation 2017 ·International Journal of Cancer ·Maike Busch, (unknown), (unknown), Manfred Beier, Harald Stephan, Brigitte Royer‐Pokora, K. Metz, Nicole Dünker	35
4	Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation 2014 ·Human Molecular Genetics ·Maike Busch, (unknown), (unknown), Manfred Beier, (unknown), Paul J. Romaniuk, Eneda Toska, Stefan G. E. Roberts, Hans‐Dieter Royer, Brigitte Royer‐Pokora	13
5	Adjuvant chemotherapy (ACT) in stage II colon cancer (CC) in patients with Lynch syndrome. 2012 ·Journal of Clinical Oncology ·Karsten Schulmann, (unknown), Christoph Engel, (unknown), Verena Steinke, Brigitte Royer‐Pokora, Hans K. Schackert, Magnus von Knebel Doeberitz, Elke Holinski‐Feder, Reinhard Büttner, Wolff Schmiegel	1
6	WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing 2011 ·Cancer Cell ·Elianna Amin, Sebastian Oltean, Jing Hua, Melissa V. Gammons, Maryam Hamdollah‐Zadeh, Gavin I. Welsh, Man‐Kim Cheung, Lan Ni, Satoru Kase, Emma Rennel, Kirsty E. Symonds, Dawid G. Nowak, Brigitte Royer‐Pokora, Moin A. Saleem, Masatoshi Hagiwara, Valerié Schumacher, Steven J. Harper, David R. Hinton, David O. Bates, Michael Ladomery	202
7	Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells 2009 ·Cancer Research ·Niels Eckstein, Kati Servan, Barbara Hildebrandt, (unknown), Georg von Jonquières, (unknown), (unknown), Alexandra Hamacher, Matthias U. Kassack, Jan Budczies, Manfred Beier, Manfred Dietel, Brigitte Royer‐Pokora, Carsten Denkert, Hans‐Dieter Royer	134
8	Ulna/Height Ratio as Clinical Parameter Separating EXT1 from EXT2 Families? 2008 ·Genetic Testing ·Barbara Leube, Karin Hardt, (unknown), Bettina Westhoff, Markus Jäger, Rüdiger Krauspe, Brigitte Royer‐Pokora	5
9	Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study 2008 ·Hematological Oncology ·Frank Neumann, (unknown), Roland Fenk, (unknown), (unknown), (unknown), (unknown), Michael Wulfert, Brigitte Royer‐Pokora, Ralf Kronenwett, Rainer Haas, Norbert Gattermann	1
10	Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC 2008 ·European Journal of Human Genetics ·Monika Morak, Hans Konrad Schackert, Nils Rahner, Beate Betz, Matthias Ebert, Constanze Walldorf, Brigitte Royer‐Pokora, Karsten Schulmann, Magnus von Knebel Doeberitz, Wolfgang Dietmaier, Gisela Keller, (unknown), (unknown), Elke Holinski‐Feder	79
11	A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2 2007 ·Leukemia ·Qi Wang, Ying Zhang, (unknown), Wei Yuan, (unknown), Brigitte Royer‐Pokora, Tao Zhu	10
12	Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia 2006 ·Cancer Genetics and Cytogenetics ·Detlef Trost, Barbara Hildebrandt, Manfred Beier, (unknown), Ulrich Germing, Brigitte Royer‐Pokora	18
13	Slow progressive FSGS associated with an F392L WT1 mutation 2004 ·Pediatric Nephrology ·(unknown), (unknown), Brigitte Royer‐Pokora, (unknown), Arvydas Laurinavičius	14
14	Unbalanced cryptic translocation der(14)t(9;14)(q34.3;q32.33) identified by subtelomeric FISH 2003 ·Clinical Dysmorphology ·Barbara Leube, Frank Majewski, Matthias Drechsler, Brigitte Royer‐Pokora	5
15	Quantitative real‐time reverse‐transcription polymerase chain reaction for diagnosis of BCR‐ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation 2003 ·European Journal Of Haematology ·Frank Neumann, (unknown), Barbara Hildebrandt, Guido Kobbe, Manuel Aivado, (unknown), (unknown), (unknown), Roland Fenk, P. Schneider, Norbert Gattermann, Brigitte Royer‐Pokora, Rainer Haas, Ralf Kronenwett	29
16	Bilateral Wilms Tumor in a Boy with Severe Hypospadias and Cryptorchidism Due to a Heterozygous Mutation in the WT1 Gene 1999 ·Pediatric Research ·Birgit Köhler, Valerié Schumacher, (unknown), (unknown), Thomas Lennert, Dagmar l’Allemand, Brigitte Royer‐Pokora, Annette Grüters	23
17	Ten novel mutations found in aniridia 1998 ·Human Mutation ·Matthias T. F. Wolf, Birgit Lorenz, Andreas Winterpacht, Matthias Drechsler, Valerié Schumacher, Brigitte Royer‐Pokora, A. Blankenagel, Bernhard Zabel, G. Wildhardt	5
18	Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations 1998 ·Kidney International ·Valerié Schumacher, K Schärer, Elke Wühl, H. Altrogge, (unknown), M. Guschmann, Thomas J. Neuhaus, Rosa Maria Pollastro, Eberhard Kuwertz-Bröking, M. Bulla, (unknown), Peter Mündel, Udo Helmchen, R Waldherr, Angela Weirich, Brigitte Royer‐Pokora	105
19	Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations 1993 ·Human Genetics ·Susanne A. Schneider, G. Wildhardt, R. Ludwig, Brigitte Royer‐Pokora	39
20	In vitro transformation with avian myelocytomatosis virus strain CMII: Characterization of the virus and its target cells 1977 ·Virology ·Thomas Graf, Brigitte Royer‐Pokora, (unknown), Michael Claviez, (unknown), Hartmut Beug	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact